Type II variation for application Roszdravnadzor-2021-0019. Type II variation: Labeling Change for Brextanib — critical change

Variation Number
Roszdravnadzor-2021-0019-V019
Type
Type II
Status
Submitted
Fee
€12,359
Submitted
2023-05-12
Approved
—
Description

Type II variation: Labeling Change for Brextanib — critical change